Abstract
The treatment of patients with acute myeloid leukaemia (AML) continues to present oncologists and haematologists with some of their more formidable problems. However, in recent months higher complete remission rates have been reported (Gale et al., 1977; Rees et al., 1977).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gale, R. P. and Cline, M. J. (1977). Lancet i,497.
Rees, J. K. H., Sandler, R. M., Challener, J. and Hayhoe, F. G. J. (1977). Br.J. Cancer, 36, 770.
Editor information
Editors and Affiliations
Copyright information
© 1979 J. K. H. Rees
About this chapter
Cite this chapter
Rees, J.K.H. (1979). Early Experience in the use of CNS Prophylactic Therapy in the Management of Patients with Acute Myeloid Leukaemia. In: Whitehouse, J.M.A., Kay, H.E.M. (eds) CNS Complications of Malignant Disease. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-04285-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-349-04285-2_8
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-04287-6
Online ISBN: 978-1-349-04285-2
eBook Packages: MedicineMedicine (R0)